Intended for healthcare professionals


Ecstasy is making a comeback, European drugs report warns

BMJ 2016; 353 doi: (Published 31 May 2016) Cite this as: BMJ 2016;353:i3078
  1. Rory Watson
  1. Lisbon

Methylenedioxymethamfetamine (MDMA), most commonly used in the form of “ecstasy” tablets, is returning as a stimulant drug of choice for young people in Europe, stated the European Monitoring Centre for Drugs and Drug Addiction in its annual report presented in Lisbon, Portugal, on 31 May.1

The report estimated that, after a decline from the peak MDMA usage levels in the early to mid-2000s, 2.1 million people aged 15 to 34 used ecstasy in the past year. Increases in use have been recorded in nine countries, with pronounced rises taking place in Bulgaria, Finland, France, England, and Wales.

The drugs agency pointed out that, whereas the …

View Full Text

Log in

Log in through your institution


* For online subscription